Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Intervalo de año de publicación
1.
Curr Med Sci ; 42(3): 613-619, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35678916

RESUMEN

OBJECTIVE: The purpose of the study was to evaluate the efficiency of the supine roll test (SRT) and alternative positional tests (APTs) including the bow and lean test (BLT), pseudo-spontaneous nystagmus (PSN), and lying down nystagmus (LDN) to identify the affected side in horizontal canal benign paroxysmal positional vertigo (HC-BPPV). METHODS: In our prospective study, we performed a testing profile (PSN, BLT, LDN, SRT) on 59 HC-BPPV patients using videonystagmography. We compared the accuracy and sensitivity of these tests in HC-BPPV lateralization. Data from 30 healthy patients were collected as the control group. RESULTS: When performing positional tests, the elicited nystagmus coinciding with Ewald's second law was defined as a "positive response". In 44 patients with geotropic nystagmus, the rates of positive response in LDN, PSN, and BLT were 22/44 (50%), 19/44 (43%), and 18/44 (41%), respectively, while in 15 patients with apogeotropic nystagmus, the positive response rates of these three tests were 10/15 (66.7%), 9/15 (60%), and 4/15 (27.00%), respectively. The sensitivity of LDN (54.38%) was higher than that of PSN (47.37%) and BLT (38.60%) but lower than that of SRT (89.47%). Notably, the accuracy rate of PSN (71.8%) was higher than that of the other APTs. In 6 patients with symmetrical nysgtamus during the roll test, 5 patients showed a positive response in both LDN and BLT (83.34%), whereas 4 patients showed a positive response in PSN (66.67%). CONCLUSION: All positional tests are helpful for determining the affected side of HC-BPPV, but SRT carries the highest accuracy of lateralization followed by PSN.


Asunto(s)
Vértigo Posicional Paroxístico Benigno , Nistagmo Patológico , Vértigo Posicional Paroxístico Benigno/diagnóstico , Humanos , Postura/fisiología , Estudios Prospectivos , Canales Semicirculares
2.
J Huazhong Univ Sci Technolog Med Sci ; 36(5): 736-740, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27752909

RESUMEN

The purpose of the study was to observe changes in endolymphatic hydrops by using intratympanic injection of gadolinium and magnetic resonance imaging (MRI) before and after endolymphatic sac surgery in patients with unilateral Meniere's disease. Thirteen patients with unilateral Meniere's disease undergoing endolymphatic sac surgery were retrospectively and prospectively analyzed. Three-dimensional fluid-attenuated inversion recovery or three-dimensional real inversion recovery MRI was performed 24 h after an intratympanic injection of gadolinium to grade the presence of endolymphatic hydrops. Among the 13 patients with hydrops confirmed by preoperative MRI, vestibular hydrops had no significant change in all patients; cochlear hydrops became negative in 2 patients, and remained unchanged in the other 11 patients after surgery. Definite vertigo attacks were substantially controlled in one patient and completely controlled in 12 patients during a follow-up period of 8-34 months after surgery. The hearing levels were improved in 3 patients, remained unchanged in 7 patients, and decreased in 3 patients. In conclusion, endolymphatic sac surgery does not always alleviate endolymphatic hydrops in patients with Meniere's disease. Relief from vertigo cannot always be attributed to the remission of hydrops. A change in hearing levels cannot be explained by hydrops status alone.


Asunto(s)
Hidropesía Endolinfática/diagnóstico por imagen , Saco Endolinfático/diagnóstico por imagen , Imagen por Resonancia Magnética , Enfermedad de Meniere/diagnóstico por imagen , Adulto , Anciano , Medios de Contraste/administración & dosificación , Hidropesía Endolinfática/patología , Hidropesía Endolinfática/cirugía , Saco Endolinfático/patología , Saco Endolinfático/cirugía , Femenino , Gadolinio/administración & dosificación , Humanos , Imagenología Tridimensional , Masculino , Enfermedad de Meniere/patología , Enfermedad de Meniere/cirugía , Persona de Mediana Edad
3.
Artículo en Inglés | WPRIM (Pacífico Occidental) | ID: wpr-820635

RESUMEN

OBJECTIVE@#To investigate the expression of soluble vascular endothelial growth factor receptor-1 (sFlt-1) and placental growth factor (PLGF) in the fetal growth restriction (FGR) cases and the intervention mechanism of tetramethylpyrazine.@*METHODS@#A total of 60 fetal growth restriction cases that admitted to our hospital were randomly divided into ligustrazine intervention group (group A) and nutritional support group (group B). A total of 50 healthy pregnant women were also enrolled as control group (group C). Expression level of maternal serum sFlt1, PLGF and fetal growth parameters including HC, AC, FL, BPD, EFW as well as placenta PLGF, sFlt-1 mRNA expression were recorded and compared among the three groups. A total of 15 SD rats were selected and were divided into three groups, TMP group, alcohol and tobacco group and blank control group. Three groups of rats were dissected on the twentieth day of gestation.@*RESULTS@#Expression level of sFlt-1 and PLGF in group A was not significantly different from that of group C (P>0.05); but significant difference in SFlt1 and PLGF expression level was observed between group C and group B (P0.05). There was significant difference in PLGF between FGR group with treatment and FGR group without treatment or control group (P<0.01).@*CONCLUSIONS@#PLGF level is decreased and sFlt-1 increased in patients suffered from fetal growth restriction, and FGR rats show increased sFlt-1 and decreased PLGF, thus they can be indicator of the fetal growth restriction. Ligustrazine can effectively improve sFlt-1, PLGF expression level in fetal growth restriction cases, which can be used as treatment for FGR.


Asunto(s)
Animales , Femenino , Humanos , Embarazo , Ratas , Desarrollo Fetal , Retardo del Crecimiento Fetal , Quimioterapia , Metabolismo , Placenta , Metabolismo , Factor de Crecimiento Placentario , Proteínas Gestacionales , Sangre , Genética , Metabolismo , Pirazinas , Farmacología , Usos Terapéuticos , ARN Mensajero , Sangre , Genética , Metabolismo , Ratas Sprague-Dawley , Receptor 1 de Factores de Crecimiento Endotelial Vascular , Sangre , Genética , Metabolismo , Vasodilatadores , Farmacología , Usos Terapéuticos
4.
Acta Pharmaceutica Sinica ; (12): 609-613, 2012.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-276272

RESUMEN

This study is to investigate the effect and mechanism of puerarin on DNA damage of HaCaT cells induced by UVB. Puerarin pre-treated cells were irradiated with UVB at 30 mJ x cm(-2). Twenty four hours after irradiation, DNA damage was detected by comet assay, ceramide was measured by thin layer chromatography and gas chromatography, intracellular free calcium ion was analyzed by flow cytometry, the phosphorylation level of p38 protein was examined by Western blotting method. Levels of DNA damage, ceramide, free calcium ion and p-p38 protein were elevated in UVB model cells. Contrary to the model group, all indicators above were reduced in all groups pre-treated by puerarin. Puerarin restrains the ceramide accumulation to block downstream p38 MAPK pathway and calcium ion rising, therefore reduces DNA damage in HaCaT cells induced by UVB.


Asunto(s)
Humanos , Calcio , Metabolismo , Línea Celular , Ceramidas , Metabolismo , Daño del ADN , Efectos de la Radiación , Regulación hacia Abajo , Isoflavonas , Farmacología , Queratinocitos , Biología Celular , Metabolismo , Fosforilación , Transducción de Señal , Rayos Ultravioleta , Proteínas Quinasas p38 Activadas por Mitógenos , Metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA